{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "BIONOMICS ADR/1/180", "longName": "Bionomics Limited", "messageBoardId": "finmb_3331473", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": 5.6818194, "regularMarketPrice": 1.86, "marketState": "REGULAR", "firstTradeDateMilliseconds": 1640588400000, "priceHint": 4, "epsTrailingTwelveMonths": -1.96, "sharesOutstanding": 8159640, "bookValue": 5.76, "fiftyDayAverage": 2.165, "fiftyDayAverageChange": -0.30499995, "fiftyDayAverageChangePercent": -0.14087757, "twoHundredDayAverage": 5.07045, "twoHundredDayAverageChange": -3.2104497, "twoHundredDayAverageChangePercent": -0.63316864, "marketCap": 21859092, "priceToBook": 0.32291666, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "regularMarketChange": 0.100000024, "regularMarketTime": 1683872402, "regularMarketDayHigh": 1.86, "regularMarketDayRange": "1.86 - 1.86", "regularMarketDayLow": 1.86, "regularMarketVolume": 70, "regularMarketPreviousClose": 1.76, "bid": 1.8, "ask": 2.4, "fullExchangeName": "Frankfurt", "financialCurrency": "AUD", "regularMarketOpen": 1.86, "averageDailyVolume3Month": 5, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.51, "fiftyTwoWeekLowChangePercent": 0.37777776, "fiftyTwoWeekRange": "1.35 - 9.4", "fiftyTwoWeekHighChange": -7.5399995, "fiftyTwoWeekHighChangePercent": -0.80212766, "fiftyTwoWeekLow": 1.35, "fiftyTwoWeekHigh": 9.4, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "B1N0.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "200 Greenhill Road", "city": "Eastwood", "state": "SA", "zip": "5063", "country": "Australia", "phone": "61 8 8150 7400", "website": "https://www.bionomics.com.au", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Adrian  Hinton BEC, F.C.A.", "age": 70, "title": "Acting Chief Financial Officer", "yearBorn": 1952, "fiscalYear": 2022, "totalPay": {"raw": 219076, "fmt": "219.08k", "longFmt": "219,076"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Connor  Bernstein M.Sc.", "age": 34, "title": "VP of Strategy & Corp. Devel.", "yearBorn": 1988, "fiscalYear": 2022, "totalPay": {"raw": 233419, "fmt": "233.42k", "longFmt": "233,419"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Spyridon  Papapetropoulos M.D., Ph.D.", "age": 48, "title": "CEO, Pres & Director", "yearBorn": 1974, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Paul  Rolan D.C.P.S.A., F.F.P.M., F.R.A.C.P., M.B.B.S., M.D.", "title": "Consultant Chief Medical Officer of Clinical Neuroscience", "fiscalYear": 2019, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Suzanne  Irwin B.Com., FCIS", "title": "Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}